MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
GKOS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Glaukos (GKOS) Ownership - Who owns Glaukos?

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
907
Web
https://www.glaukos.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
7.42B
P/E Ratio
N/A
Total Cash
276.69M
Projected Growth
N/A
Total Debt
103.06M
Revenue
551.35M
Risk (Beta)
1.43
Dividend Yield
N/A
Total Cash/Share
4.71
Total Debt/Equity
N/A
Revenue/Share
9.58 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GKOS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for GKOS
A.I. Advisor
published General Information

General Information

an ophthalmic medical device company

Industry MedicalNursingServices

Profile
Details
Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
907
Web
https://www.glaukos.com